Temsirolimus is used to treat advanced kidney cancer and previously treated mantle cell lymphoma (lung cancer affecting lymph nodes).
How it works
Temsirolimus belongs to class of medications called mammalian target of rapamycin (mTOR) inhibitors. Temsirolimus works by inhibiting a human protein chemical called mTOR thereby blocking tumor or cancer growth.
Common side effects
Vomiting, Nausea, Pale colored skin, Frequent urge to urinate, Difficulty in urination, Acne, Facial swelling, Allergic reaction, Swelling of mouth, Lip swelling, Joint pain, Blood in urine, Bloody nose, Change in toe nails, Change in finger nails, Constipation, Depression, Dry skin, Fatigue, Insomnia, Itching, Loss of appetite, Muscle pain, Back pain, Eye redness, Swelling, Skin redness, Tachycardia, Throat swelling, Weakness, Drowsiness, Headache
- 1 variant(s)
- Temsirolimus contains high levels of alcohol and should be taken with caution if you take alcohol in large quantities or if you have to drive or operate heavy machinery
Frequently asked questions
Q. Is temsirolimus a chemotherapy agent?
Yes, temsirolimus is a chemotherapy agent and is used in the treatment of certain types of cancers like kidney cancer and mantle cell lymphoma (a type of cancer of lymph nodes immune cells)
Q. Is temsirolimus cytotoxic, a kinase inhibitor?
Yes, temsirolimus is cytotoxic and kinase inhibitor.
Q. Is temsirolimus a vesicant?
Temsirolimus is not a vesicant (irritant) drug.
Q. What is temsirolimus used for?
Temsirolimus is used to treat advanced kidney cancer and previously treated mantle cell lymphoma (a type of lung cancer affecting lymph nodes).
Q. How does temsirolimus work?
Temsirolimus works by inhibiting a human protein chemical called mammalian target of rapamycin (mTOR) thereby blocking tumor or cancer growth.